Press Release: François-Xavier Roger appointed Chief Financial Officer, member of Sanofi Executive Committee
01 Febbraio 2024 - 7:30AM
Press Release: François-Xavier Roger appointed Chief Financial
Officer, member of Sanofi Executive Committee
François-Xavier Roger appointed Chief Financial
Officer, member of Sanofi Executive Committee
Paris, February 1, 2024.
François-Xavier Roger will be appointed Chief Financial Officer and
a member of Sanofi’s Executive Committee effective April 1, 2024.
He will be based in Paris and will succeed Jean-Baptiste Chasseloup
de Chatillon who will step down from his role to become Head of
Apprentis d’Auteuil. Apprentis d’Auteuil is a foundation that
supports adolescents who are struggling in life by providing
education, training and integration programs, in France and
internationally. Being active in charity work for many years,
Jean-Baptise decided to devote the next stage of his career to
giving back to society.
François-Xavier will join from Nestle, where he
has been the CFO for more than 8 years, providing strong financial
leadership and driving sustainable value creation. He is a seasoned
executive who has lived and worked in Europe, the U.S, Asia, Africa
and Latin America. Before Nestlé, François-Xavier was the CFO
of Takeda Pharmaceuticals, based in Japan, from 2013 to 2015.
François-Xavier started his career in pharma, spending the first 14
years at Roussel, Hoechst and Aventis, in various countries. From
2000 to 2008, François-Xavier was the CFO for Danone Asia, after
which he was Head of Finance, Treasury and Tax for the Danone
Group. Between 2008 to 2013, he was CFO of Millicom, a NASDAQ
listed, global mobile phone operator.
Paul HudsonChief Executive
Officer, Sanofi“As we enter the next phase of launch and growth,
it’s a pleasure to welcome onboard François-Xavier Roger, a CFO
with a proven track record in accelerated value creation. Since
joining in 2018, Jean-Baptiste de Chatillon has been instrumental
in progressing our Play to Win Strategy. Under his leadership, our
finance organization has been modernized into a team that supports
our mission and execution of our strategy on a daily basis. We are
proud of Jean-Baptiste’s next step.”
Jean-Baptise Chasseloup de
Chatillon“Over these last 5 years, I have been privileged
to witness the incredible transformation of Sanofi into a company
with a strong long-term growth potential. My decision to head
Apprentis d’Auteuil was also fuelled by my growing passion for the
impact Sanofi has around the world. I thank Paul and all my
colleagues at Sanofi for their trust over the years and will be
applauding them as they continue to drive forward our
strategy.”
François-Xavier Roger“It is
with great enthusiasm that I join Sanofi in this dynamic moment
marked by significant transformation. I am excited by the
opportunity to further improve patient outcomes and deliver
increased shareholder value in the years to come.”
Picture of François-Xavier Roger is attached to this
email.
About SanofiWe are an innovative global
healthcare company, driven by one purpose: we chase the miracles of
science to improve people’s lives. Our team, across some 100
countries, is dedicated to transforming the practice of medicine by
working to turn the impossible into the possible. We provide
potentially life-changing treatment options and life-saving vaccine
protection to millions of people globally, while putting
sustainability and social responsibility at the center of our
ambitions. Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY
Media RelationsSandrine
Guendoul | + 33 6 25 09 14 25
| sandrine.guendoul@sanofi.comNicolas
Obrist | + 33 6 77 21 27 55
| nicolas.obrist@sanofi.comVictor
Rouault | + 33 6 70 93 71 40
| victor.rouault@sanofi.com
Investor RelationsEva
Schaefer-Jansen | + 33 7 86 80 56 39
| eva.schaefer-jansen@sanofi.comArnaud
Delépine | + 33 6 73 69 36 93 |
arnaud.delepine@sanofi.comCorentine
Driancourt | + 33 6 40 56 92 21 |
corentine.driancourt@sanofi.comFelix
Lauscher | + 1 908 612 7239 |
felix.lauscher@sanofi.comTarik Elgoutni| + 1 617
710 3587 | tarik.elgoutni@sanofi.comNathalie
Pham | + 33 7 85 93 30 17 |
nathalie.pham@sanofi.com
- Press_Release
- François_Xavier_Roger_Picture
Grafico Azioni Sanofi (BIT:1SAN)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Sanofi (BIT:1SAN)
Storico
Da Apr 2023 a Apr 2024
